Task: Answer the multiple-choice question.
Question: Which drug exhibits a 4.894% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1cccc(CNc2ncc(-c3cccc([N+](=O)[O-])c3)n2C)c1.O=C(O)C(=O)O
b: Cc1ccc(-c2csc3ncnc(SCC(=O)O)c23)cc1
Answer: b. Cc1ccc(-c2csc3ncnc(SCC(=O)O)c23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2csc3ncnc(SCC(=O)O)c23)cc1
Cc1ccc(-c2csc3ncnc(SCC(=O)O)c23)cc1
2-[5-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]sulfanylacetic acid